Investor Relations

Corporate Profile

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.

Read more

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Sign Up For E-Mail Alerts

Sign Up